Purification and characterization of trypanothione reductase from Crithidia fasciculata, a new member of the family of disulfide-containing flavoprotein reductases, Biochemistry, vol.25, issue.12, pp.3519-3526, 1986. ,
DOI : 10.1021/bi00360a007
Polyamine metabolism in Leishmania: from arginine to trypanothione, Amino Acids, vol.272, issue.Pt 2, pp.269-285, 2011. ,
DOI : 10.1007/s00726-010-0630-3
Trypanosomatidae Diseases: From the Current Therapy to the Efficacious Role of Trypanothione Reductase in Drug Discovery, Current Medicinal Chemistry, vol.20, issue.21, pp.2673-2696, 2013. ,
DOI : 10.2174/0929867311320210005
Proliferation, ACS Medicinal Chemistry Letters, vol.2, issue.3, pp.230-233, 2011. ,
DOI : 10.1021/ml1002629
Trypanothione Reductase But Not of Human Glutathione Reductase, Journal of Medicinal Chemistry, vol.43, issue.25, pp.4812-4821, 2000. ,
DOI : 10.1021/jm000219o
Gold complexes as potential anti-parasitic agents, Coordination Chemistry Reviews, vol.253, issue.11-12, pp.1619-1626, 2009. ,
DOI : 10.1016/j.ccr.2008.12.003
A gold-containing drug against parasitic polyamine metabolism: the X-ray structure of trypanothione reductase from Leishmania infantum in complex with auranofin reveals a dual mechanism of enzyme inhibition, Amino Acids, vol.281, issue.3, pp.803-811, 2012. ,
DOI : 10.1007/s00726-011-0997-9
Outstanding plasmodicidal properties within a small panel of metallic compounds: Hints for the development of new metal-based antimalarials, Journal of Inorganic Biochemistry, vol.103, issue.2, pp.310-312, 2008. ,
DOI : 10.1016/j.jinorgbio.2008.10.004
Gold(III) Complexes with Bipyridyl Ligands:?? Solution Chemistry, Cytotoxicity, and DNA Binding Properties, Journal of Medicinal Chemistry, vol.45, issue.8, pp.1672-1677, 2002. ,
DOI : 10.1021/jm010997w
Synthesis, Structural Characterization, Solution Behavior, and in Vitro Antiproliferative Properties of a Series of Gold Complexes with 2-(2???-Pyridyl)benzimidazole as Ligand: Comparisons of Gold(III) versus Gold(I) and Mononuclear versus Binuclear Derivatives, Inorganic Chemistry, vol.51, issue.5, pp.3161-3171, 2012. ,
DOI : 10.1021/ic202639t
Gold(III) Adducts with Chiral Pyridinyl-Oxazolines. Synthesis, Reactivity of the Coordinated Ligands, and Structural Characterizations, Organometallics, vol.28, issue.24, pp.7015-7024, 2009. ,
DOI : 10.1021/om900841b
Structural and solution chemistry, protein binding and antiproliferative profiles of gold(I)/(III) complexes bearing the saccharinato ligand, Journal of Inorganic Biochemistry, vol.105, issue.3, pp.348-355, 2011. ,
DOI : 10.1016/j.jinorgbio.2010.11.016
Structural and Solution Chemistry, Antiproliferative Effects, and DNA and Protein Binding Properties of a Series of Dinuclear Gold(III) Compounds with Bipyridyl Ligands, Journal of Medicinal Chemistry, vol.49, issue.18, pp.5524-5531, 2006. ,
DOI : 10.1021/jm060436a
Gold(III) complexes with 2-substituted pyridines as experimental anticancer agents: Solution behavior, reactions with model proteins, antiproliferative properties, Journal of Inorganic Biochemistry, vol.108, pp.123-127, 2012. ,
DOI : 10.1016/j.jinorgbio.2011.11.007
Exploring the biochemical mechanisms of cytotoxic gold compounds: a proteomic study, JBIC Journal of Biological Inorganic Chemistry, vol.49, issue.4, pp.573-582, 2010. ,
DOI : 10.1007/s00775-010-0624-3
Molecular mechanisms of antimony resistance in Leishmania, Journal of Medical Microbiology, vol.56, issue.2, pp.143-153, 2007. ,
DOI : 10.1099/jmm.0.46841-0
Trypanothione Reductase from Leishmania infantum: Cloning, Expression, Purification, Crystallization and Preliminary X-Ray Data Analysis, Protein & Peptide Letters, vol.16, issue.2, pp.196-200, 2009. ,
DOI : 10.2174/092986609787316306